Moderna
MRNA
#963
Rank
C$35.89 B
Marketcap
C$90.46
Share price
3.50%
Change (1 day)
160.04%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -C$4.29 Billion

According to Moderna 's latest financial reports the company's current earnings are C$2.20 Billion. In 2025 the company made an earning of -C$3.91 Billion, an increase over its 2024 earnings that were of -C$5.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$4.29 Billion9.88%
2025 -C$3.91 Billion-23.03%
2024 -C$5.07 Billion-8.22%
2023 -C$5.53 Billion-140.65%
2022 C$13.58 B-27.81%
2021 C$18.81 B-1911.15%
2020 -C$1.04 Billion44.7%
2019 -C$0.72 Billion28.63%
2018 -C$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.74 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.32 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$18.60 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-C$67.08 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$59.07 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.22 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$0.48 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA